Supplementary Figure S1 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma
Authors:
- Kai YuKYKai Yu
- Rebecca S. TidwellRebecca S. Tidwell
- Tharakeswara K. BathalaTharakeswara K. Bathala
- Rahul A. ShethRahul A. Sheth
- Menuka KarkiMKMenuka Karki
- Jianfeng ChenJCJianfeng Chen
- Jing QianJQJing Qian
- Fei DuanFDFei Duan
- Luigi PerelliLuigi Perelli
- Melinda SoeungMelinda Soeung
- Priya RaoPriya Rao
- Arlene O. Siefker-RadtkeArlene O. Siefker-Radtke
Open Access
- 29 July 2026
- other
- Published by American Association for Cancer Research (AACR)